相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience
Blake Hugo Fortes et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2021)
Ocular Complications of Checkpoint Inhibitors and Immunotherapeutic Agents: A Case Series
Ruby A. Parikh et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2021)
Fundus autofluorescence imaging
Steffen Schmitz-Valckenberg et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2021)
Immune Checkpoint Inhibitor-associated Uveitis: Review of Treatments and Outcomes
Eliot R. Dow et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2021)
Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition
Michel M. Sun et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
Local therapy for cancer therapy-associated uveitis: a case series and review of the literature
Arthi Ganesh Venkat et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Melanoma-associated retinopathy
S. Elsheikh et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo A Secondary Analysis of a Randomized Clinical Trial
Alexander M. M. Eggermont et al.
JAMA ONCOLOGY (2020)
Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma
S. Yoshida et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)
Concurrent Vogt-Koyanagi-Harada disease and impressive response to immune checkpoint blockade in metastatic melanoma
T. Gambichler et al.
IMMUNOTHERAPY (2020)
Vogt-Koyanagi-Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report
Ryo Kikuchi et al.
BMC OPHTHALMOLOGY (2020)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Satya Das et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Prevalence and Clinical Patterns of Ocular Complications Associated With Anti-PD-1/PD-L1 Anticancer Immunotherapy
Karen Bitton et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis
Murat Hasanreisoglu et al.
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY (2019)
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
Giovanni Fuca et al.
ESMO OPEN (2019)
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Shumpei Obata et al.
CASE REPORTS IN OPHTHALMOLOGY (2019)
Checkpoint inhibitor-induced uveitis: a case series
Christopher D. Conrady et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)
Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 28, pg 119, 2017)
J. B. A. G. Haanen et al.
ANNALS OF ONCOLOGY (2018)
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis Fundamentals Of Care for UveitiS (FOCUS) Initiative
Andrew D. Dick et al.
OPHTHALMOLOGY (2018)
CHECKPOINT INHIBITOR IMMUNE THERAPY Systemic Indications and Ophthalmic Side Effects
Lauren A. Dalvin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)
Clinical Analysis of 42 Cases of Ocular Ischemic Syndrome
Jingyi Luo et al.
JOURNAL OF OPHTHALMOLOGY (2018)
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small Cell Lung Cancer
Koji Haratani et al.
JAMA ONCOLOGY (2018)
The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy
Arabella Young et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
I. Puzanov et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Immune-checkpoint blockade - durable cancer control
Elizabeth I. Buchbinder et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
Troy Z. Horvat et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Indocyanine green angiography in posterior uveitis
Rupesh V. Agrawal et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2013)
Melanoma-Associated Retinopathy A Paraneoplastic Autoimmune Complication
Ying Lu et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
分享论文
